These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28903506)

  • 21. Serotype emergence and genotype distribution among macrolide-resistant invasive Streptococcus pneumoniae isolates in the postconjugate vaccine (PCV-7) era.
    Liu Z; Nachamkin I; Edelstein PH; Lautenbach E; Metlay JP
    Antimicrob Agents Chemother; 2012 Feb; 56(2):743-50. PubMed ID: 22123697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population genetic structure, serotype distribution and antibiotic resistance of
    Gagetti P; Lo SW; Hawkins PA; Gladstone RA; Regueira M; Faccone D; Sireva-Argentina Group ; Klugman KP; Breiman RF; McGee L; Bentley SD; Corso A
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34586054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central Greece.
    Grivea IN; Sourla A; Ntokou E; Chryssanthopoulou DC; Tsantouli AG; Syrogiannopoulos GA
    BMC Infect Dis; 2012 Oct; 12():255. PubMed ID: 23057516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.
    Tomczyk S; Lynfield R; Schaffner W; Reingold A; Miller L; Petit S; Holtzman C; Zansky SM; Thomas A; Baumbach J; Harrison LH; Farley MM; Beall B; McGee L; Gierke R; Pondo T; Kim L
    Clin Infect Dis; 2016 May; 62(9):1119-25. PubMed ID: 26908787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological and molecular characterization of invasive Streptococcus pneumoniae isolated following introduction of 7-valent conjugate vaccine in Kinki region, Japan, 2008-2013.
    Toda H; Tanaka Y; Satoh K; Komatsu M; Wada Y; Tobe T; Kamisako T
    J Infect Chemother; 2020 May; 26(5):451-458. PubMed ID: 31870586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.
    Rudolph K; Bruce MG; Bulkow L; Zulz T; Reasonover A; Harker-Jones M; Hurlburt D; Hennessy TW
    Int J Circumpolar Health; 2013; 72():. PubMed ID: 23984273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology Characteristics of
    Zhao W; Pan F; Wang B; Wang C; Sun Y; Zhang T; Shi Y; Zhang H
    Front Cell Infect Microbiol; 2019; 9():258. PubMed ID: 31380301
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.
    Galanis I; Lindstrand A; Darenberg J; Browall S; Nannapaneni P; Sjöström K; Morfeldt E; Naucler P; Blennow M; Örtqvist Å; Henriques-Normark B
    Eur Respir J; 2016 Apr; 47(4):1208-18. PubMed ID: 26797033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.
    González-Díaz A; Càmara J; Ercibengoa M; Cercenado E; Larrosa N; Quesada MD; Fontanals D; Cubero M; Marimón JM; Yuste J; Ardanuy C
    Clin Microbiol Infect; 2020 Jun; 26(6):753-759. PubMed ID: 31756452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010-2020.
    Link-Gelles R; Taylor T; Moore MR;
    Vaccine; 2013 May; 31(22):2572-7. PubMed ID: 23583813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs.
    Perdrizet J; Wilson M; Wannaadisai W; Apodaca K; Grant L
    Expert Rev Vaccines; 2024; 23(1):879-886. PubMed ID: 39329476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study.
    Picazo JJ; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Amo MD; Méndez C;
    Vaccine; 2019 Apr; 37(16):2200-2207. PubMed ID: 30902478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
    van der Linden M; Falkenhorst G; Perniciaro S; Imöhl M
    PLoS One; 2015; 10(7):e0131494. PubMed ID: 26132078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
    J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.